Cargando…
The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications
BACKGROUND: Translating prognostic and diagnostic biomarker candidates into clinical applications takes time, is very costly, and many candidates fail. It is therefore crucial to be able to select those biomarker candidates that have the highest chance of successfully being adopted in the clinic. Th...
Autores principales: | de Graaf, Gimon, Postmus, Douwe, Westerink, Jan, Buskens, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006586/ https://www.ncbi.nlm.nih.gov/pubmed/29946228 http://dx.doi.org/10.1186/s12962-018-0105-z |
Ejemplares similares
-
Using Multicriteria Decision Analysis to Support Research Priority Setting in Biomedical Translational Research Projects
por: de Graaf, Gimon, et al.
Publicado: (2015) -
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
por: Cao, Qi, et al.
Publicado: (2018) -
Programme costs in the economic evaluation of health interventions
por: Johns, Benjamin, et al.
Publicado: (2003) -
Differential discounting in the economic evaluation of healthcare programs
por: John, Jürgen, et al.
Publicado: (2019) -
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
por: Thorn, Joanna C., et al.
Publicado: (2021)